Avantyo Newsletter My account Search Calendar
Next: Clinical Trials Symposium on 18th November, 2022

About the impact of COVID-19 pandemic on the clinical trial community while FDA and EMA debate (separately) on the approval of the anti-COVID-19 vaccine

Back to all news

About the impact of COVID-19 pandemic on the clinical trial community while FDA and EMA debate (separately) on the approval of the anti-COVID-19 vaccine

Dr Cristina Florescu Moraid talks about the impact of the pandemic on the clinical trials community and about the experience in this regard, as reflected by the speakers participating in the Clinical Studies Symposium 2020 as the first speaker during the special edition of  #RaportuldegardăLIVE, from the 10th of December 2020.

This marathon edition of Raportul de Garda broadcasts the public consultation where FDA (Food and Drug Agency) debates on the urgent approval of the anti-Covid19 vaccine developed by Pfizer and BioNTech. We can say that this is a historical decision to be taken and a historical day.

The broadcast is a dialogue between Dr Marius Geanta President of InoMed, Dr Cristna Florescu Moraid CEO AVANTYO and President of the Clinical Trials Symposium, and Dr Bianca Cocos and it is moderated by Adriana Boata editor and anchor at RaportuldeGarda. 

Dr Florescu opens the list of the guest invited to speak during the marathon transmission.

Late edit on December 11, 2020

Another special LIVE edition of #Raportuldegardă to discuss with Romanian specialist the context of the Public Meeting organized by the European Medicines Agency (EMA) to debate the conditional marketing authorization of the Pfizer-BioNTech vaccine for the prevention of # COVID19. From 17:30 (4:02 in the recording), Dr Cristina Florescu Moraid, talked about the importance of clinical trials, from the perspective of this vaccine against Covid-19.

Posted on: 11 December 2020